About AtaCor Medical
AtaCor Medical is a company based in San Clemente (United States) founded in 2014 by Alan Marcovecchio, Rick Sanghera, and Sean McGeehan. AtaCor Medical has raised $136.8 million across 4 funding rounds from investors including Longview Partners, Broadview Ventures and aMoon. The company has 15 employees as of December 31, 2022. AtaCor Medical offers products and services including EV Temporary Pacing Lead System and EV-ICD Lead System. AtaCor Medical operates in a competitive market with competitors including AtriCure, CardioFocus, Kestra Medical Technologies, EBR Systems and AuriGen Medical, among others.
- Headquarter San Clemente, United States
- Employees 15 as on 31 Dec, 2022
- Founders Alan Marcovecchio, Rick Sanghera, Sean McGeehan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Atacor Medical, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$136.8 M (USD)
in 4 rounds
-
Latest Funding Round
$75 M (USD), Series D
Oct 06, 2025
-
Investors
Longview Partners
& 6 more
-
Employee Count
15
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AtaCor Medical
AtaCor Medical offers a comprehensive portfolio of products and services, including EV Temporary Pacing Lead System and EV-ICD Lead System.
Provides temporary pacing without entering the heart or vascular system.
Delivers defibrillation and ATP without transvenous leads for safety.
People of AtaCor Medical
Unlock access to complete
Unlock access to complete
Funding Insights of AtaCor Medical
AtaCor Medical has successfully raised a total of $136.8M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $75 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AtaCor Medical
AtaCor Medical has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Longview Partners, Broadview Ventures and aMoon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-stage life sciences investments are made in the US.
|
Locked | Locked | Locked | |
|
Venture capital investments in healthcare are focused on by aMoon.
|
Locked | Locked | Locked | |
|
Tech & Life Sciences focused VC firm investing in early stage companies in the US & Europe
|
Locked | Locked | Locked |
Investor details for AtaCor Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AtaCor Medical
Investment portfolio details for AtaCor Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AtaCor Medical
Detailed financials for AtaCor Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Atacor Medical Comparisons
Peer comparison for AtaCor Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AtaCor Medical
AtaCor Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AtriCure, CardioFocus, Kestra Medical Technologies, EBR Systems and AuriGen Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiac ablation and occlusion devices for atrial fibrillation are provided.
|
|
| Locked | Locked | Locked |
Endoscopic catheter for atrial fibrillation ablation is developed.
|
|
| Locked | Locked | Locked |
Medical devices are developed to support cardiovascular patients at risk.
|
|
| Locked | Locked | Locked |
Wireless cardiac pacing devices are developed for left ventricle stimulation.
|
|
| Locked | Locked | Locked |
Trans-septal implants for atrial fibrillation treatment are developed.
|
Detailed competitors of AtaCor Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Atacor Medical
Complete news archive for AtaCor Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AtaCor Medical
AtaCor Medical was founded in 2014 and raised its 1st funding round 4 years after it was founded.
AtaCor Medical is headquartered in San Clemente, United States. It is registered at San Clemente, California, United States.
Rick Sanghera is the current CEO of AtaCor Medical. They have also founded this company.
AtaCor Medical is a funded company, having raised a total of $136.8M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at AtaCor Medical is 15.
Founded in 2014 and based in San Clemente, United States, AtaCor Medical operates in the medical device sector. An implantable pacemaker system is being developed, with the lead positioned in tissue above the heart to deliver pacing therapy. No leads or hardware are required inside or on the heart. Ventricular pacing or AV synchronous nodal therapy is enabled through this approach.
AtaCor Medical's top competitors include AtriCure, CardioFocus and Kestra Medical Technologies.
AtaCor Medical offers EV Temporary Pacing Lead System and EV-ICD Lead System.
AtaCor Medical has 7 investors. Key investors include Longview Partners, Broadview Ventures, aMoon, Hatteras Venture Partners, and CHV.